TrialPath
Recruiting

Acupressure for the Reduction of Anxiety in Patients Receiving Cancer-Directed Therapy

NCT06723041 · Mayo Clinic
In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

Official title
Acupressure for Anxiety: A Randomized Controlled Trial of an Acupressure Intervention for Patients Receiving Cancer-Directed Therapy
About this study
PRIMARY OBJECTIVE: I. To test the efficacy of a nurse-applied acupressure intervention for anxiety associated with active cancer-directed therapy. SECONDARY OBJECTIVES: I. To test the efficacy of a patient-applied acupressure intervention for anxiety associated with active cancer-directed therapy. II. To assess whether acupressure appears to improve nausea related to cancer and cancer-directed therapy. OUTLINE: Patients are randomized to 1 of 2 arms. ARM I: Patients undergo true acupressure over 10 minutes on study. Patients that choose to learn self-administration acupressure at home receive educational information and undergo self-administration acupressure sessions at least twice daily (BID) for seven days. ARM II: Patients undergo sham acupressure over 10 minutes on study. Patients that choose to learn self-administration acupressure at home receive educational information and undergo self-administration acupressure sessions at least BID for seven days.
Eligibility criteria
Inclusion Criteria: * NURSE-LED INTERVENTION: Age \>= 18 years and be diagnosed with cancer * NURSE-LED INTERVENTION: Undergoing systemic, antineoplastic therapy * NURSE-LED INTERVENTION: Ability to provide oral consent * NURSE-LED INTERVENTION: Willingness to undergo a nurse-led acupressure intervention * NURSE-LED INTERVENTION: Willingness and ability to complete pre- and post-intervention questionnaires in English * NURSE-LED INTERVENTION: Report acute anxiety as a 5 or higher on a scale for 0 (no anxiety) to 10 (severe anxiety) * SELF-ADMINISTRATION INTERVENTION: Age \>= 18 years and be diagnosed with cancer * SELF-ADMINISTRATION INTERVENTION: Undergoing systemic, antineoplastic therapy * SELF-ADMINISTRATION INTERVENTION: Ability to provide oral consent * SELF-ADMINISTRATION INTERVENTION: Willingness to undergo a nurse-led acupressure intervention * SELF-ADMINISTRATION INTERVENTION: Willingness and ability to complete pre- and post-intervention questionnaires in English * SELF-ADMINISTRATION INTERVENTION: Report acute anxiety as a 5 or higher on a scale for 0 (no anxiety) to 10 (severe anxiety) * SELF-ADMINISTRATION INTERVENTION: Reports 2+/day anxiety episodes at home * SELF-ADMINISTRATION INTERVENTION: Interested in learning self-administered acupressure Exclusion Criteria: * Prior experiences with acupressure, or training in acupressure points
Study design
Enrollment target: 78 participants
Allocation: randomized
Masking: single
Age groups: adult, older_adult
Timeline
Starts: 2024-12-11
Estimated completion: 2028-12-31
Last updated: 2026-05-28
Interventions
Procedure: Acupressure TherapyProcedure: Acupressure Therapy - placeboProcedure: Acupressure Therapy - self-administeredOther: Health Promotion and EducationOther: Survey Administration
Primary outcomes
  • Change in acute anxiety (Up to 2 weeks)
Sponsor
Mayo Clinic · other
Contacts & investigators
ContactClinical Trials Referral Office · contact · mayocliniccancerstudies@mayo.edu · 855-776-0015
ContactJennifer Manggaard · contact · Manggaard.Jennifer@mayo.edu · 507-255-7768
InvestigatorElizabeth Cathcart-Rake, MD · principal_investigator, Mayo Clinic in Rochester
All locations (1)
Mayo Clinic in RochesterRecruiting
Rochester, Minnesota, United States